Search

Jon B Korshus

from Minneapolis, MN
Deceased
Get Report
Related to:
Tanya M Howard, 48Ehren Korshus, 45Omer KorshusDorothy KorshusStephanie E Korshus, 39
Connected to:
Lucky A Korsinah, 64Martin H Korsin, 66Stefen D Korsko, 67Michelle C Korslin, 42Pamela D Korsman, 56Robert Korsmeyer, 56Andrew N Korsmo, 46Helen L Korsmo, 115Jay R Korsmo, 67Lee S Korsmo, 36

Jon Korshus Phones & Addresses

  • 7500 York Ave, Minneapolis, MN 55435 (952) 831-7973
  • 7500 York Ave S #842, Minneapolis, MN 55435 (952) 831-7973

Resumes

Resumes

Jon Korshus Photo 1

Jon Korshus

View page
Location:
Minneapolis, MN
Industry:
Biotechnology
Work:
DiaSorin Inc. since Oct 2010
Quality Systems Specialist
WuXi AppTec, Inc. Jan 2006 - Jul 2010
Manager, Virology Testing
Education:
University of Minnesota-Twin Cities
MS, Microbiology
Skills:
Microbiology
Fda
Glp
Virology
Quality System
Capa
Vaccines
V&V
Laboratory
Testing
Gmp
Iso 13485
Lims
Medical Devices
Sop
Quality Control
Regulatory Affairs
Validation
Jon Korshus Photo 2

Quality Assurance Engineer

View page
Location:
Minneapolis, MN
Work:

Quality Assurance Engineer

Publications

Us Patents

Borrelia Burgdorferi Bacterin

View page
US Patent:
20020071851, Jun 13, 2002
Filed:
Aug 14, 2001
Appl. No.:
09/930657
Inventors:
Jon Korshus - Minneapolis MN, US
Paul Runnels - Floyd IA, US
Richard Sharpee - Green Oaks IL, US
Ronald Schell - Madison WI, US
Steven Callister - Onalaska WI, US
Assignee:
Solvay Animal Health, Inc.
International Classification:
A61K039/02
C12N001/21
US Classification:
424/234100, 435/252300
Abstract:
A bacterin including effective immunizing amounts of two non-crossprotective isolates of inactivated , an adjuvant in an amount effective to enhance the immunogenicity of the inactivated isolates and a suitable carrier is provided herein. The bacterin may also contain a third non-crossprotective isolate. A bacterin including effective immunizing amounts of an antigenic subunit derived from a first Borrelia burgdorferi isolate and a second, non-crossprotective isolate, an adjuvant in an amount effective to enhance the immunogenicity of the antigenic subunits and a suitable carrier is also provided. The bacterin may also contain an effective immunizing amount of an antigenic subunit of a third . Further provided is a bacterin which includes effective immunizing amounts of two non-crossprotective isolates of inactivated and one or more antigenic subunits from the non-crossprotective isolates, an adjuvant in an amount effective to enhance the immunogenicity of the inactivated and antigenic subunits and a suitable carrier.

Borrelia Burgdorferi Bacterin

View page
US Patent:
20050042235, Feb 24, 2005
Filed:
Jun 11, 2004
Appl. No.:
10/866512
Inventors:
Jon Korshus - Lakeville MN, US
Paul Runnels - Floyd IA, US
Richard Sharpee - Green Oaks IL, US
Ronald Schell - Madison WI, US
Steven Callister - Onalaska WI, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K039/02
C12N001/20
US Classification:
424234100, 435252300
Abstract:
A bacterin including effective immunizing amounts of two non-crossprotective isolates of inactivated , an adjuvant in an amount effective to enhance the immunogenicity of the inactivated isolates and a suitable carrier is provided herein. The bacterin may also contain a third non-crossprotective isolate. A bacterin including effective immunizing amounts of an antigenic subunit derived from a first isolate and a second, non-crossprotective isolate, an adjuvant in an amount effective to enhance the immunogenicity of the antigenic subunits and a suitable carrier is also provided. The bacterin may also contain an effective immunizing amount of an antigenic subunit of a third . Further provided is a bacterin which includes effective immunizing amounts of two noncrossprotective isolates of inactivated and one or more antigenic subunits from the non-crossprotective isolates, an adjuvant in an amount effective to enhance the immunogenicity of the inactivated and antigenic subunits and a suitable carrier.

Borrelia Burgdorferi Bacterin

View page
US Patent:
20080026009, Jan 31, 2008
Filed:
Jul 9, 2007
Appl. No.:
11/774968
Inventors:
Jon Korshus - Minneapolis MN, US
Paul Runnels - Floyd IA, US
Richard Sharpee - Green Oaks IL, US
Ronald Schell - Madison WI, US
Steven Callister - Onalaska WI, US
International Classification:
A61K 39/02
A61P 31/04
US Classification:
424234100
Abstract:
A bacterin including effective immunizing amounts of two non-crossprotective isolates of inactivated , an adjuvant in an amount effective to enhance the immunogenicity of the inactivated isolates and a suitable carrier is provided herein. The bacterin may also contain a third non-crossprotective isolate. A bacterin including effective immunizing amounts of an antigenic subunit derived from a first isolate and a second, non-crossprotective isolate, an adjuvant in an amount effective to enhance the immunogenicity of the antigenic subunits and a suitable carrier is also provided. The bacterin may also contain an effective immunizing amount of an antigenic subunit of a third . Further provided is a bacterin which includes effective immunizing amounts of two non-crossprotective isolates of inactivated and one or more antigenic subunits from the non-crossprotective isolates, an adjuvant in an amount effective to enhance the immunogenicity of the inactivated and antigenic subunits and a suitable carrier.

Borrellia Burgdorferi Bacterin

View page
US Patent:
20110256178, Oct 20, 2011
Filed:
Apr 21, 2011
Appl. No.:
13/091824
Inventors:
Jon B. KORSHUS - Lakeville MN, US
Paul L. Runnels - Floyd IA, US
Richard L. Sharpee - Green Oaks IL, US
Ronald F. Schell - Madison WI, US
Steven M. Callister - Onalaska WI, US
International Classification:
A61K 39/02
A61P 31/04
A61P 37/04
US Classification:
4242341
Abstract:
A bacterin including effective immunizing amounts of two non-crossprotective isolates of inactivated , an adjuvant in an amount effective to enhance the immunogenicity of the inactivated isolates and a suitable carrier is provided herein. The bacterin may also contain a third non-crossprotective isolate. A bacterin including effective immunizing amounts of an antigenic subunit derived from a first isolate and a second, non-crossprotective isolate, an adjuvant in an amount effective to enhance the immunogenicity of the antigenic subunits and a suitable carrier is also provided. The bacterin may also contain an effective immunizing amount of an antigenic subunit of a third . Further provided is a bacterin which includes effective immunizing amounts of two non-crossprotective isolates of inactivated and one or more antigenic subunits from the non-crossprotective isolates, an adjuvant in an amount effective to enhance the immunogenicity of the inactivated and antigenic subunits and a suitable carrier.

Borrelia Burgdorferi Bacterin

View page
US Patent:
63160056, Nov 13, 2001
Filed:
Jan 21, 1997
Appl. No.:
8/722013
Inventors:
Jon B. Korshus - Minneapolis MN
Paul L. Runnels - Floyd IA
Richard L. Sharpee - Green Oaks IL
Ronald F. Schell - Madison WI
Steven M. Callister - Onalaska WI
Assignee:
Solvay Animal Health, Inc. - Mendota Heights MN
International Classification:
A61K 3902
A61K 39116
A61K 3900
A01N 6300
US Classification:
4242341
Abstract:
A bacterin including effective immunizing amounts of two non-crossprotective isolates of inactivated Borrelia burgdorferi, an adjuvant in an amount effective to enhance the immunogenicity of the inactivated Borrelia burgdorferi isolates and a suitable carrier is provided herein. The bacterin may also contain a third non-crossprotective isolate. A bacterin including effective immunizing amounts of an antigenic subunit derived from a first Borrelia burgdorferi isolate and a second, non-crossprotective Borrelia burgdorferi isolate, an adjuvant in an amount effective to enhance the immunogenicity of the antigenic subunits and a suitable carrier is also provided. The bacterin may also contain an effective immunizing amount of an antigenic subunit of a third Borrelia burgdorferi. Further provided is a bacterin which includes effective immunizing amounts of two non-crossprotective isolates of inactivated Borrelia burgdorferi and one or more antigenic subunits from the non-crossprotective isolates, an adjuvant in an amount effective to enhance the immunogenicity of the inactivated Borrelia burgdorferi and antigenic subunits and a suitable carrier. Methods of immunizing an animal against Borrelia burgdorferi infection which comprise administering to the animal a dose of a bacterin provided herein are also provided.
Control profile
Jon B Korshus from Minneapolis, MNDeceased Get Report